Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lumican accumulates with fibrillar collagen in fibrosis in hypertrophic cardiomyopathy
Chloe Rixon, Kristine Andreassen, Xin Shen, et al.
ESC Heart Failure (2022) Vol. 10, Iss. 2, pp. 858-871
Open Access | Times Cited: 23

Showing 23 citing articles:

Lumican promotes calcific aortic valve disease through H3 histone lactylation
Yuming Huang, Chunli Wang, Tingwen Zhou, et al.
European Heart Journal (2024) Vol. 45, Iss. 37, pp. 3871-3885
Closed Access | Times Cited: 47
2024 update in heart failure
Alberto Beghini, Antonio Maria Sammartino, Z. Papp, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 31
Myocardial fibrosis from the perspective of the extracellular matrix: mechanisms to clinical impact
Ida G. Lunde, Karoline Bjarnesdatter Rypdal, Sophie Van Linthout, et al.
Matrix Biology (2024) Vol. 134, pp. 1-22
Closed Access | Times Cited: 7
Characterization of a robust mouse model of heart failure with preserved ejection fraction
Dzmitry Matsiukevich, Attila Kovács, Tiandao Li, et al.
AJP Heart and Circulatory Physiology (2023) Vol. 325, Iss. 2, pp. H203-H231
Closed Access | Times Cited: 14
The relationship between serum Lumican levels and myocardial fibrosis in patients with hypertrophic cardiomyopathy
Emirhan Hancıoğlu, Sevgi Özcan, Esra Dönmez, et al.
Biomarkers in Medicine (2025), pp. 1-9
Closed Access
Lumican as a potential biomarker for diabetic nephropathy
Yuejia Tao, Yipeng Liu, Zunsong Wang, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access
Thrown for a loop: fibro-adipogenic progenitors in skeletal muscle fibrosis
Taryn Loomis, Lucas Smith
AJP Cell Physiology (2023) Vol. 325, Iss. 4, pp. C895-C906
Closed Access | Times Cited: 9
Lumican, a Multifunctional Cell Instructive Biomarker Proteoglycan Has Novel Roles as a Marker of the Hypercoagulative State of Long Covid Disease
Margaret M. Smith, James Melrose
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2825-2825
Open Access | Times Cited: 3
Transcriptome and proteome revealed the differences in 3 colors of earlobe in Jiangshan Black-bone chicken
Shiru Li, Yu Du, Xue Du, et al.
Poultry Science (2024) Vol. 103, Iss. 8, pp. 103864-103864
Open Access | Times Cited: 3
Editors' highlight picks from 2023 in ESC heart failure
Magnus Bäck, Stephan von Haehling, Zoltán Papp, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 3, pp. 1283-1289
Open Access | Times Cited: 1
The role of the CXCR6/CXCL16 axis in the pathogenesis of fibrotic disease
Fang‐Tao Wang, Tian-Qi Wu, Yin Lin, et al.
International Immunopharmacology (2024) Vol. 132, pp. 112015-112015
Closed Access | Times Cited: 1
Identification of ATRNL1 and WNT9A as novel key genes and drug candidates in hypertrophic cardiomyopathy: integrative bioinformatics and experimental validation
Huabin He, Yanhui Liao, Yang Chen, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 1
Exploration of Mediators Associated with Myocardial Remodelling in Feline Hypertrophic Cardiomyopathy
Wan-Ching Cheng, Charlotte Lawson, Hui-Hsuan Liu, et al.
Animals (2023) Vol. 13, Iss. 13, pp. 2112-2112
Open Access | Times Cited: 3
Downregulation of B4GALT5 attenuates cardiac fibrosis through Lumican and Akt/GSK-3β/β-catenin pathway
Xutao Zhang, Shengyu Cui, Yuewen Ding, et al.
European Journal of Pharmacology (2023) Vol. 963, pp. 176263-176263
Closed Access | Times Cited: 2
Lumican Is Both a Novel Risk Factor and Potential Plasma Biomarker for Vascular Aging, Capable of Promoting Vascular Smooth Cells Senescence Through Interacting With Integrin α2β1
Mandi Luo, Dan Yan, Yi Huang, et al.
The Journals of Gerontology Series A (2024) Vol. 80, Iss. 1
Open Access
Single‐Nucleus RNA Sequencing Unravels Early Mechanisms of Human Becker Muscular Dystrophy
Zhihao Xie, Chang Liu, Chengyue Sun, et al.
Annals of Neurology (2024) Vol. 96, Iss. 6, pp. 1070-1085
Closed Access
The Extracellular Matrix and Cardiac Pressure Overload: Focus on Novel Treatment Targets
Matthijs Snelders, Murat Yıldırım, A.H. Jan Danser, et al.
Cells (2024) Vol. 13, Iss. 20, pp. 1685-1685
Open Access
Identification of novel key genes and signaling pathways in hypertrophic cardiomyopathy: evidence from bioinformatics and next generation sequencing data analysis
Basavaraj Vastrad, Chanabasayya Vastrad
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The Role of the Extracellular Matrix in Cardiac Regeneration
Xiying Wang, Shuo Yu, Lan Xie, et al.
Heliyon (2024) Vol. 11, Iss. 1, pp. e41157-e41157
Open Access
Beneficial effects of exercise initiated before development of hypertrophic cardiomyopathy in genotype-positive mice
Kristine Andreassen, Chloe Rixon, Marie Haugsten Hansen, et al.
AJP Heart and Circulatory Physiology (2023) Vol. 324, Iss. 6, pp. H881-H892
Closed Access | Times Cited: 1
Small Leucine Rich Proteoglycan in Fibrotic Diseases: New Frenemies?
Jiayu Guo, Yan Wang, Haihai Liang, et al.
International Journal of Drug Discovery and Pharmacology (2023), pp. 61-78
Open Access | Times Cited: 1
Functionally similar genes exhibit comparable/similar time-course expression kinetics in the UV-induced photoaged mouse model
Seon‐Pil Jin, Joong Heon Suh, Chang-Eop Kim, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0290358-e0290358
Open Access | Times Cited: 1
Page 1

Scroll to top